Everfront Biotech Co., Ltd.
Clinical trials sponsored by Everfront Biotech Co., Ltd., explained in plain language.
A biotech company developing treatments for central nervous system disorders.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
A wafer implanted directly into pancreatic tumors: can it help?
Disease control Not yet recruitingResearchers are testing a wafer called EF-009 that surgeons place directly onto pancreatic tumors during a minimally invasive operation. The trial enrolls adults with borderline resectable or unresectable pancreatic cancer, meaning tumors that surgery may or may not be able to re…
Phase 1/2 • Sponsor: Everfront Biotech Co., Ltd. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New brain cancer wafer shows promise in recurrent glioblastoma trial
Disease control Not yet recruitingThis study tests a new treatment called Cerebraca Wafer for people with recurrent glioblastoma, a serious brain cancer. The wafer is placed in the brain during surgery and is followed by standard chemotherapy. The goal is to see if it helps people live longer and controls the dis…
Phase 2/3 • Sponsor: Everfront Biotech Co., Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC